Enrique A. Conterno
2018
In 2018, Enrique A. Conterno earned a total compensation of $5M as Senior Vice President and President, Lilly Diabetes and President, Lilly USA at Lilly Eli & Co, a 42% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,099,842 |
|---|---|
| Salary | $794,683 |
| Stock Awards | $3,057,600 |
| Other | $47,681 |
| Total | $4,999,806 |
Conterno received $3.1M in stock awards, accounting for 61% of the total pay in 2018.
Conterno also received $1.1M in non-equity incentive plan, $794.7K in salary and $47.7K in other compensation.
Rankings
In 2018, Enrique A. Conterno's compensation ranked 2,010th out of 14,244 executives tracked by ExecPay. In other words, Conterno earned more than 85.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,010 out of 14,244 | 86th |
Division Manufacturing | 723 out of 5,765 | 88th |
Major group Chemicals And Allied Products | 238 out of 2,128 | 89th |
Industry group Drugs | 189 out of 1,817 | 90th |
Industry Pharmaceutical Preparations | 147 out of 1,391 | 89th |
Source: SEC filing on March 22, 2019.
Conterno's colleagues
We found five more compensation records of executives who worked with Enrique A. Conterno at Lilly Eli & Co in 2018.